Molecular targets in melanoma: time for 'ethnic personalization'

Shane Y Morita1, Svetomir N Markovic

  • 1The Queen's Medical Center/Queen's Cancer Center, 1301 Punchbowl Street, Honolulu, HI 96813, USA.

Insights

Melanoma incidence is rising globally. Recent studies examine melanoma's molecular characteristics across diverse ethnicities, including Asians, to improve treatment for all patients.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Melanoma incidence is increasing worldwide, posing a significant public health challenge.
  • Despite being less common than other skin cancers, melanoma is the most lethal.
  • Targeted therapies have lagged in melanoma compared to other cancers, until recent advancements.

Purpose of the Study:

  • To investigate the molecular characteristics of melanoma in diverse ethnic populations.
  • To understand the role of specific genes (c-KIT, BRAF, NRAS) in melanoma across different ethnicities.
  • To explore the potential for universally applicable melanoma management strategies.

Main Methods:

  • Analysis of molecular profiles (c-KIT, BRAF, NRAS) in melanoma samples.
  • Comparison of genetic mutations across various ethnic groups, including Asians and Caucasians.
  • Review of recent scientific literature on melanoma biology and targeted therapies.

Main Results:

  • Novel data on the molecular characterization of melanoma in Asian populations have been identified.
  • Specific genetic mutations (c-KIT, BRAF, NRAS) show variations across different ethnic groups.
  • The study provides insights into the biological differences of melanoma based on ethnicity.

Conclusions:

  • Understanding ethnic variations in melanoma molecular biology is crucial for effective treatment.
  • Targeted therapies, like BRAF inhibitors, show promise but require further ethnic-specific investigation.
  • The goal is to develop melanoma management strategies that are effective for all ethnic groups.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...